Rising Lung Cancer Burden Attributable to High Fasting Plasma Glucose in Women Aged ≥50 Years: Age-, SDI-, and BRICS-Specific Patterns from GBD 1990–2021
Oncology · 01.06.2026 · 1-10
DOI: 10.1159/000552661 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, online erschienen am 01.06.2026. Verfasst von Lili Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Pharmaceutical University First Affiliated Hospital, Guangzhou, China. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Introduction
We quantified trends and heterogeneity in lung cancer burden attributable to high fasting plasma glucose (HFPG) among women aged ≥50 years (used as a population-level proxy for postmenopausal status) globally and across BRICS countries from 1990 to 2021.
Methods
HFPG-attributable lung cancer deaths and disability-adjusted life years (DALYs) for women aged ≥50 years were obtained from Global Burden of Disease 1990–2021. Burden was summarized as numbers and age-standardized rates (ASR) per 100,000, stratified by age, Socio-demographic Index (SDI) quintile, and country. Trends were assessed using estimated annual percentage change (EAPC) from log-linear regression.
Results
Global HFPG-attributable deaths and DALYs increased markedly from 1990 to 2021, with rising ASR (global EAPC 1.21; 95% CI, 1.11–1.31). A strong age gradient was observed; EAPC increased from 0.53% (50–54 years) to 3.65% (≥95 years). In 2021, the DALYs ASR peaked in the 75–79 years group (59.38 per 100,000). High-SDI settings consistently had the highest ASR and increasing burden. In BRICS, the ASR of DALYs increased in all five countries with substantial heterogeneity; India showed the fastest increase (EAPC 3.05; 95% CI, 2.91–3.19), followed by South Africa (2.82; 2.64–3.00), and Brazil (2.36; 2.31–2.42), while China showed the smallest increase (0.87; 0.70–1.03).
Conclusion
HFPG-attributable lung cancer burden in women aged ≥50 years rose substantially from 1990 to 2021, with disproportionate growth in older ages and clear SDI/BRICS differences, supporting integrated metabolic prevention within cancer control and healthy aging strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Pharmaceutical University First Affiliated Hospital, Guangzhou, China.
- Guangdong Pharmaceutical University First Affiliated Hospital, Guangzhou, China, zz_lam@163.com.
Zitieren
APA
Lin, L., Huang, X., Li, B., Li, J., & Chen, H. (2026). Rising Lung Cancer Burden Attributable to High Fasting Plasma Glucose in Women Aged ≥50 Years: Age-, SDI-, and BRICS-Specific Patterns from GBD 1990–2021. Oncology, 1-10. https://doi.org/10.1159/000552661
Vancouver
Lin L, Huang X, Li B, Li J, Chen H. Rising Lung Cancer Burden Attributable to High Fasting Plasma Glucose in Women Aged ≥50 Years: Age-, SDI-, and BRICS-Specific Patterns from GBD 1990–2021. Oncology. 2026:1-10. doi:10.1159/000552661
BibTeX
@article{Lin2026,
author = {Lin, Lili and Huang, Xiaoqin and Li, Bijun and Li, Jinjian and Chen, Hui},
title = {Rising Lung Cancer Burden Attributable to High Fasting Plasma Glucose in Women Aged ≥50 Years: Age-, SDI-, and BRICS-Specific Patterns from GBD 1990–2021},
journal = {Oncology},
year = {2026},
pages = {1--10},
doi = {10.1159/000552661}
}
EUVIMED